Drug Profile
Rimcazole
Alternative Names: BW 234ULatest Information Update: 17 Jul 2019
Price :
$50
*
At a glance
- Originator University of Dundee
- Developer Istesso
- Class Antipsychotics; Carbazoles; Small molecules
- Mechanism of Action Sigma-1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Cancer in United Kingdom (PO)
- 16 Apr 2008 Phase-I clinical trials in Cancer in United Kingdom (PO)
- 02 Aug 2007 Modern Biosciences granted a worldwide, exclusive license to rimcazole for cancer